Dashboard
Manage Tickers

LLYELI LILLY & Co

NYSE lilly.com


$ 815.00 $ 4.75 (0.59 %)    

Thursday, 23-May-2024 11:41:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 454.82 $ -1.95 (-0.42 %)
DIA $ 398.57 $ -2.93 (-0.74 %)
SPY $ 530.36 $ -2.01 (-0.38 %)
TLT $ 91.26 $ -0.81 (-0.88 %)
GLD $ 225.37 $ -2.09 (-0.95 %)
$ 802.91
$ 810.25
$ 723.00 x 165
$ 815.05 x 100
$ 803.50 - $ 815.21
$ 416.69 - $ 816.61
1,767,519
na
725.67B
$ 0.57
$ 118.22
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-30-2024 03-31-2024 10-Q
2 02-21-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 04-27-2023 03-31-2023 10-Q
6 02-22-2023 12-31-2022 10-K
7 11-01-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 04-29-2022 03-31-2022 10-Q
10 02-23-2022 12-31-2021 10-K
11 10-27-2021 09-30-2021 10-Q
12 08-03-2021 06-30-2021 10-Q
13 04-30-2021 03-31-2021 10-Q
14 02-17-2021 12-31-2020 10-K
15 10-28-2020 09-30-2020 10-Q
16 07-31-2020 06-30-2020 10-Q
17 05-01-2020 03-31-2020 10-Q
18 02-19-2020 12-31-2019 10-K
19 10-25-2019 09-30-2019 10-Q
20 08-02-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 02-19-2019 12-31-2018 10-K
23 11-06-2018 09-30-2018 10-Q
24 07-25-2018 06-30-2018 10-Q
25 04-27-2018 03-31-2018 10-Q
26 02-20-2018 12-31-2017 10-K
27 10-27-2017 09-30-2017 10-Q
28 07-28-2017 06-30-2017 10-Q
29 05-01-2017 03-31-2017 10-Q
30 02-21-2017 12-31-2016 10-K
31 10-28-2016 09-30-2016 10-Q
32 07-28-2016 06-30-2016 10-Q
33 04-29-2016 03-31-2016 10-Q
34 02-19-2016 12-31-2015 10-K
35 10-30-2015 09-30-2015 10-Q
36 07-30-2015 06-30-2015 10-Q
37 04-30-2015 03-31-2015 10-Q
38 02-19-2015 12-31-2014 10-K
39 10-29-2014 09-30-2014 10-Q
40 07-28-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Lexaria Awards Contract To A CRO To Perfor...
05/23/2024 14:56:55

First-ever DehydraTECH-processed tirzepatide from Zepbound® to be tested in a swallowed oral formatKELOWNA, BC / ACCESSWIRE / M...

australia-bans-replica-versions-of-popular-weight-loss-drugs-from-novo-nordisk-eli-lilly-on-safety-concerns
Australia Bans Replica Versions Of Popular...
05/22/2024 15:46:57

Compounding weight loss drugs, which are similar to brand-name medications such as Ozempic and Mounjaro, will be banned in Aust...

this-biotech-stock-is-poised-for-80-upside-with-breakthrough-in-obesity-drug-market-says-jpmorgan
This Biotech Stock Is Poised For 80% Upsid...
05/22/2024 02:41:37

The Structure Therapeutics stock has been identified as a potential winner in the obesity drug market. JPMorgan has given the s...

exclusive-roundhill-investments-launches-weight-loss-etf-for-exposure-to-blockbuster-drugs-like-ozempic
EXCLUSIVE: Roundhill Investments Launches ...
05/21/2024 20:33:05

Roundhill CEO Dave Mazza says investors "can't just buy a basket of big pharma names or a broad-based biotech ETF and c...

the-ozempic-diet-nestle-launches-5-pizza-for-weight-loss-drug-users
The Ozempic Diet: Nestle Launches $5 Pizza...
05/21/2024 18:25:52

Nestlé SA launches Vital Pursuit, a new food line tailored for GLP-1 weight loss medication users, featuring protein, fiber, an...

Core News & Articles
Novo Nordisk CEO, On Lilly's Diabetes Drug...
05/21/2024 14:53:10

- Reuters

eli-lilly-secures-china-nod-for-popular-weight-lossdiabetes-drug-tirzepatide
Eli Lilly Secures China Nod For Popular We...
05/21/2024 13:36:01

Eli Lilly's diabetes drug tirzepatide receives approval in China, intensifying competition with Novo Nordisk's Ozempic....

more-than-one-half-of-patients-with-crohns-disease-treated-with-lillys-mirikizumab-achieved-clinical-remission-at-one-year-including-patients-with-previous-biologic-failure
More Than One-Half Of Patients With Crohn'...
05/21/2024 12:06:37

heres-how-much-100-invested-in-eli-lilly-and-co-5-years-ago-would-be-worth-today
Here's How Much $100 Invested In Eli Lilly...
05/20/2024 17:30:44

evaluating-eli-lilly-and-co-against-peers-in-pharmaceuticals-industry
Evaluating Eli Lilly and Co Against Peers ...
05/17/2024 15:00:16

eli-lillys-weekly-insulin-dose-on-par-with-commonly-used-daily-doses-phase-3-studies-show
Eli Lilly's Weekly Insulin Dose On Par Wit...
05/16/2024 14:13:00

Eli Lilly phase 3 trials reveal once-weekly insulin efsitora as a non-inferior alternative to daily basal insulins for type 2 d...

eli-lillys-qwint-2-and-qwint-4-phase-3-trials-of-once-weekly-insulin-efsitora-in-type-2-diabetes-patients-using-insulin-for-first-time-and-require-multiple-daily-injections-efsitora-showed-non-inferior-a1c-reduction-vs-most-commonly-used-daily-insulin
Eli Lilly's QWINT-2 And QWINT-4 Phase 3 Tr...
05/16/2024 10:49:35

Efsitora met the primary endpoint in both QWINT-2 and QWINT-4 with once-a-week dosing regimen for people living with type 2 d...

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
05/15/2024 17:35:22

no-wegovy-shortage-in-denmark-amid-high-demand-novo-nordisk-confirms
No Wegovy Shortage in Denmark Amid High De...
05/15/2024 15:59:08

Novo Nordisk confirms there is no anticipated shortage of Wegovy in Denmark, despite prior warnings from the Danish Medicines A...

eli-lilly-strikes-deal-to-combat-counterfeit-diabetes-and-weight-loss-drugs-mounjaro-and-zepbound
Eli Lilly Strikes Deal To Combat Counterfe...
05/15/2024 14:03:37

Eli Lilly has settled with Totality Medispa over counterfeit Mounjaro and Zepbound sales. The spa will pay damages and cease us...

Core News & Articles
Eli Lilly Provides Update On Mounjaro And ...
05/14/2024 21:15:25

Core News & Articles
'Lilly Settles With Spa Selling Mounjaro, ...
05/14/2024 21:14:09

https://www.wsj.com/livecoverage/stock-market-today-dow-jones-05-14-2024/card/lilly-settles-with-spa-selling-mounjaro-zepbound-...

argus-research-maintains-buy-on-eli-lilly-and-co-raises-price-target-to-840
Argus Research Maintains Buy on Eli Lilly ...
05/14/2024 16:58:28

Argus Research analyst David Toung maintains Eli Lilly and Co (NYSE:LLY) with a Buy and raises the price target from $770 to...

pfizer-follows-eli-lillys-footsteps-to-sell-medicines-directly-to-patients
Pfizer Follows Eli Lilly's Footsteps To Se...
05/13/2024 18:22:54

Pfizer seeks to expands its reach with 'Pfizer for All,' offering direct-to-consumer medical services, including COVID ...

google-deepmind-develops-latest-ai-model-to-aid-scientists-in-fighting-disease
Google DeepMind Develops Latest AI Model T...
05/08/2024 19:19:36

Google DeepMind reveals its AlphaFold 3, which specializes in molecular predictions for proteins, DNA, RNA, and drug molecules.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION